Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes

Minimal inhibitory and fungicidal concentrations (MIC and MFC, respectively) of auranofin against 15 H. capsulatum strains with distinct genetic backgrounds were determined using the yeast form of the fungus and a microdilution protocol. Auranofin activity was also assessed on a macrophage model of infection and on a Tenebrio molitor invertebrate animal model. Expression of virulence-related genes was compared between auranofin treated and untreated H. capsulatum yeast cells using a quantitative PCR assay. Auranofin affected the growth of different strains of H. capsulatum, with MIC and MFC values ranging from 1.25 to 5.0 μM and from 2.5 to >10 μM, respectively. Auranofin was able to kill intracellular H. capsulatum yeast cells and conferred protection against the fungus in the experimental animal model of infection. Moreover, the expression of catalase A, HSP70, superoxide dismutase, thioredoxin reductase, serine proteinase, cytochrome C peroxidase, histone 2B, formamidase, metallopeptidase, Y20 and YPS3 proteins were reduced after six hours of auranofin treatment. CONCLUSIONS/SIGNIFICANCE: Auranofin is fungicidal against H. capsulatum and reduces the expression of several virulence-related genes, which makes this anti-rheumatic drug a good candidate for new medicines against histoplasmosis.

Authors

Institutions

Publication Details

Journal
PLoS neglected tropical diseases
Published
2024-10-07
DOI
https://doi.org/10.1371/journal.pntd.0012586
Citations
3
Primary Topic
Fungal Infections and Studies
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes

Carlos P. Taborda, Iara Bastos de Andrade, Rosely Maria Zancopé‐Oliveira, Marcos de Abreu Almeida et al.
3 citations
PLoS neglected tropical diseases
Fungal Infections and Studies
1.16
article

Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes

Carlos P. Taborda, Iara Bastos de Andrade, Rosely Maria Zancopé‐Oliveira, Marcos de Abreu Almeida, Leandro Buffoni Roque da Silva, Dario Corrêa-Junior, Andréa Reis Bernardes‐Engemann, Rowena Alves Coelho, Fernando Almeida‐Silva, Alexandre Alanio, Lílian Cristiane Baeza, Rodrigo Almeida‐Paes, Susana Frasés
article en
3 citations

Abstract

Minimal inhibitory and fungicidal concentrations (MIC and MFC, respectively) of auranofin against 15 H. capsulatum strains with distinct genetic backgrounds were determined using the yeast form of the fungus and a microdilution protocol. Auranofin activity was also assessed on a macrophage model of infection and on a Tenebrio molitor invertebrate animal model. Expression of virulence-related genes was compared between auranofin treated and untreated H. capsulatum yeast cells using a quantitative PCR assay. Auranofin affected the growth of different strains of H. capsulatum, with MIC and MFC values ranging from 1.25 to 5.0 μM and from 2.5 to >10 μM, respectively. Auranofin was able to kill intracellular H. capsulatum yeast cells and conferred protection against the fungus in the experimental animal model of infection. Moreover, the expression of catalase A, HSP70, superoxide dismutase, thioredoxin reductase, serine proteinase, cytochrome C peroxidase, histone 2B, formamidase, metallopeptidase, Y20 and YPS3 proteins were reduced after six hours of auranofin treatment. CONCLUSIONS/SIGNIFICANCE: Auranofin is fungicidal against H. capsulatum and reduces the expression of several virulence-related genes, which makes this anti-rheumatic drug a good candidate for new medicines against histoplasmosis.

PLoS neglected tropical diseasesVol. 18(10)
Universidade Federal do Rio de Janeiro (BR), University of British Columbia (CA), Institut Pasteur (FR), Universidade Federal Fluminense (BR), Universidade de São Paulo (BR), Universidade Estadual do Oeste do Paraná (BR), Université Paris Cité (FR), Instituto Evandro Chagas (BR), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (BR), Fundação Oswaldo Cruz (BR)
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Good health and well-being
Openalex Percentile: Top 20%
Fungal Infections and Studies
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.